NIPT Continues to Take Off in 2013 as Indications, Insurance Coverage Grow GenomeWeb ... estimated total NGS MDx market, by 2015, following by oncology testing, which it predicts to make up about a third of the market, and tests in areas such as infectious disease, HLA typing, idiopathic diseases, preventive medicine, and pharmacogenomics. |
